Companies

Verona Pharma

Overview

Verona Pharma reversed into cash shell Isis Resources on 19 September 2006. The reversal price was 4p. It specialises in developing treatments for respiratory ailments. The most advanced treatment is RPL554, which is aimed at hay fever and asthma sufferers. Management believes that it can cope with two or three projects at one time.

Sector: Health

News blog

• Verona Pharma Posted: 23/06/2014
• Verona Pharma Posted: 06/03/2014
• Verona Pharma Posted: 28/08/2012
• Verona Pharma Posted: 08/12/2011
• Verona Pharma Posted: 11/09/2009
• Verona Pharma Posted: 25/03/2009
• Verona Pharma Posted: 18/06/2008
• Verona Pharma Posted: 19/05/2008
• Verona Pharma Posted: 26/02/2008

Browse by sector

All companies

• Aim advisers
• Aim Awards
• Aim investor relations
• Cleantech
• Construction
• Consumer
• Electricals
• Financial
• Food
• Health
• Industrial
• Leisure
• Media
• Mobile
• Property
• QUOTED MICRO
• Resources
• Retail
• Security
• Services
• Technology
• Telecoms
• Training
• Transport

• 2.4mNumber of messages posted on SocialGo networks
  
• $38mCost savings generated by ideas from WalMart staff over a two month period